Abstract: This avalanche triggering system includes a portable unit configured to be carried by an operator, the portable unit comprising a gas storage device configured to store an oxidizing gas and a combustible gas; an explosion unit which is configured to be launched by the operator or to be transported by a drone and which includes a flexible envelope configured to be filled with an explosive gas mixture, the flexible envelope being deformable between a rest configuration in which the flexible envelope has a first inner volume and an inflated configuration in which the flexible envelope has a second inner volume which is greater than the first inner volume, the explosion unit further including an ignition device configured to trigger the explosion of the explosive gas mixture contained in the flexible envelope; and a control unit configured to remotely control the ignition device.

Abstract: A weightlifting and strength training apparatus intended for a full body workout. The weightlifting apparatus combines the weightlifting aspects of a yoke with the resistance training of a sled.

Abstract: Provided herein are electrically conductive scaffolds of various shapes suitable for promoting and stimulating tissue regeneration, particularly in nerve repair.

Abstract: The present invention discloses compounds according to Formula I: Wherein R1, R2, R3a, R3b, and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory conditions, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering a compound of the invention.

Abstract: A computer system may receive medical-imaging data associated with at least an individual. Then, the computer system may compute, based at least in part on the medical-imaging data, a set of white-matter disease biomarkers for different neurological anatomical regions, where, for a given neurological anatomical region, the set of white-matter disease biomarkers includes: an apparent fiber density that corresponds to a total intra-axonal volume, an amount of free water, and a demyelination metric. Next, the computer system may provide feedback information associated with at least the individual based at least in part on interrelationships among the computed set of white-matter disease biomarkers in different neurological anatomical regions. For example, the feedback information may include: diagnostic information, information associated with disease progression (such as a disease stage), information regarding efficacy of a treatment, or a treatment recommendation (e.g.

Abstract: Content can be delivered to devices via one or more networks based on clusters of attributes in some examples. As one particular example, a server can determine a first set of attributes corresponding to a cookie associated with an entity and determine a second set of attributes corresponding to a mobile advertiser identifier (MAID) associated with the entity. The server can generate a cluster of attributes for the entity based on the first set of attributes and the second set of attributes. The system can then receive audience definition criteria defining a target audience for content and determine whether the cluster of attributes satisfies the audience definition criteria. If the cluster of attributes satisfies the audience definition criteria, the server can designate the cookie and the MAID as belonging to the target audience to enable the content to be delivered to the entity.

Abstract: A computer system that computes second tractography results is described. This computer may include: a computation device (such as a processor, a graphics processing unit or GPU, etc.) that executes program instructions; and memory that stores the program instructions. During operation, the computer system receives information specifying tractography results that specify a set of neurological fibers. Then, the computer system computes, using a predetermined (e.g., pretrained) autoencoder neural network, the second tractography results that specify a second set of neurological fibers based at least in part on the tractography results and information associated with a neurological anatomical region. For example, a subset of the set of neurological fibers may be anatomically implausible and the second set of fibers may exclude the subset. Note that the predetermined autoencoder neural network may be trained using an unsupervised-learning technique.

Abstract: A method of forming a transparent, electrically-conductive film and an associated film. The method can be a transfer method. A region of a substrate is provided with a binder that includes metal nanostructures suspended in a photosensitive polymeric material. A donor substrate can be used. Photolithography is used to pattern the binder. The patterned binder is developed using a developing fluid that: (i) removes a portion of the photosensitive polymeric material according to a pattern of the binder, and (ii) includes a nanostructure etchant that etches the metal nanostructures.

Abstract: A method of forming a conductive film. The method includes applying an ink onto a substrate. The ink includes a plurality of nanostructures formed from an electrically-conductive material and a polymer binder. The method includes drying the ink on the substrate. The method includes applying an overcoat material solution onto the dried ink. The overcoat solution includes at least some solvent suitable to provide at least some solubility of the binder. Also, a conductive film that includes a substrate, a matrix on the substrate, and a plurality of nanostructures within the matrix. The matrix is provided as a resultant of a polymer binder present within an ink that carried the nanostructures that was applied and dried upon the substrate, a dried/cured overcoat material that that was applied on the dried ink layer in the form of a coating solution that included a polymer and at least some solvent to provide at least some solubility of the binder, with the binder being at least partially dissolved.

Abstract: The present invention discloses compounds according to Formula I: Wherein R1, R2, R3a, R3b, and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory conditions, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering a compound of the invention.

Abstract: Disclosed herein are optical stacks that are stable to light exposure by incorporating one or more UV-blocking layers.

Abstract: A method of forming monodispersed metal nanowires comprising; forming a reaction mixture including a metal salt, a capping agent and an ionic additive in a polar solvent at a first temperature; and forming metal nanowires by reducing the metal salt in the reaction mixture.

Abstract: Disclosed herein are optical stacks that are stable to light exposure by incorporating light-stabilizers and/or oxygen barriers.

Abstract: A flameless candle includes: a candle body; a projection screen; a supporting portion; a moving portion; an LED; and a magnetic-field-inducing circuit. The projection screen extends upwardly from an upper surface of the candle body, has a flame shape, and has a fixed position with respect to the upper surface of the candle body. The moving portion is supported by the supporting portion and includes: a transparent lens oriented diagonally; an arm extending downwardly; and a magnet on the arm. The LED is oriented to project light upwardly and diagonally such that the projected light travels through the lens, through an aperture of the upper surface of the candle body, and onto an outer surface of the projection screen. The magnetic-field-inducing circuit includes a coil that successively attracts and repels the magnet.

Abstract: The present invention discloses compounds according to Formula I: Wherein R1, R2, R3a, R3b, and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory conditions, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering a compound of the invention.

Abstract: A transparent conductor including a conductive layer coated on a substrate is described. More specifically, the conductive layer comprises a network of nanowires that may be embedded in a matrix. The conductive layer is optically clear, patternable and is suitable as a transparent electrode in visual display devices such as touch screens, liquid crystal displays, plasma display panels and the like.

Abstract: According to some embodiments, an organic device and method of forming an organic device are disclosed. A hybrid cathode layer is formed in stacked alignment with a substrate. The hybrid cathode layer includes a combination of a conductive nanowire and an electron-transport material. After forming the hybrid cathode layer, a photoactive layer is formed on a structure that includes the substrate and the hybrid cathode layer. After forming the photoactive layer, a hybrid anode layer that is separated from the hybrid cathode layer by the photoactive layer is formed. The hybrid anode layer includes a combination of a conductive nanowire and a hole-transporting material.

Abstract: A method of forming monodispersed metal nanowires comprising: forming a reaction mixture including a metal salt, a capping agent and an ionic additive in a reducing solvent; and reducing the metal salt to the monodispersed metal nanostructures.

Abstract: Disclosed herein are photo-stable optical stacks including a transparent conductive film formed by silver nanostructures or silver mesh. In particular, one or more light stabilizers (such as transition metal salts) are incorporated into one or more constituent layers of the optical stack.

Abstract: The present invention discloses compounds according to Formula I: Wherein R1, R2, R3a, R3b, R6a, R6b, the subscript n and Cy are as defined herein. The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering the compound of the invention.